About Molecular Devices
Molecular Devices is a company based in Sunnyvale (United States) founded in 1983 was acquired by Danaher in September 2009. Molecular Devices has completed 2 acquisitions, including Cellesce and LJL BioSystems. Molecular Devices offers products and services including SpectraMax Microplate Readers, SoftMax Pro Software, and CellXpress.ai Automated Cell Culture System. Molecular Devices operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molecular Devices
Molecular Devices offers a comprehensive portfolio of products and services, including SpectraMax Microplate Readers, SoftMax Pro Software, and CellXpress.ai Automated Cell Culture System.
Devices for high-throughput screening in life science assays.
Software for processing data from microplate readers.
Automated system for reliable cell culture and imaging workflows.
People of Molecular Devices
Unlock access to complete
Funding Insights of Molecular Devices
Detailed funding history for Molecular Devices
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Molecular Devices
Molecular Devices has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Danaher and mdsinc.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Dental equipment and medical instruments are manufactured for therapeutic areas.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Molecular Devices
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molecular Devices
Molecular Devices has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cellesce and LJL BioSystems.
Investment portfolio details for Molecular Devices
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Scalable processes for organoid expansion are developed.
|
Locked | Locked | 2013 | Locked | |
|
Fluorescence detection instruments for life sciences are developed.
|
Locked | Locked | 1988 | Locked |
Complete acquisition details for Molecular Devices
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Molecular Devices
Detailed financials for Molecular Devices
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Molecular Devices Comparisons
Peer comparison for Molecular Devices
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Molecular Devices
Molecular Devices operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| Locked | Locked | Locked |
Online platform offering life sciences reagents and kits
|
|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
Detailed competitors of Molecular Devices
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Molecular Devices
Complete news archive for Molecular Devices
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Devices
Molecular Devices was founded in 1983.
Molecular Devices is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Founded in 1983 and based in Sunnyvale, United States, automated solutions for life science research are offered by the company. These encompass cell culture systems, high-content imaging platforms, microplate readers, and clone screening tools. Operations focus on high-throughput screening, plate-based assays, and organoid production services, with GxP compliance support for GMPGLP laboratories. Drug discovery and cell line development are facilitated across research workflows.
Molecular Devices's top competitors include Biocare Medical, Merck and Siemens Healthineers.
Molecular Devices offers SpectraMax Microplate Readers, SoftMax Pro Software, and CellXpress.ai Automated Cell Culture System.
Molecular Devices has made 2 acquisitions, including Cellesce, and LJL BioSystems.
Molecular Devices has 2 investors. Key investors include Danaher, and mdsinc.com.